Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: December 15, 2025
Safe and Effective Addition of Ruxolitinib to Graft-versus-host Prophylaxis in Older Adults Undergoing Reduced-intensity Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: July 08, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
Journal: Leukemia & lymphoma
Published: March 12, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
Journal: Leukemia research
Published: November 07, 2024
Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects.
Journal: Transplantation and cellular therapy
Published: February 16, 2024
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide.
Journal: Bone marrow transplantation
Published: July 19, 2023
Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
Journal: Bone marrow transplantation
Published: November 18, 2022
Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults.
Journal: Leukemia & lymphoma
Published: January 25, 2022
Last Updated: 09/26/2026